Cetuximab plus radiotherapy for head and neck cancer [10]

dc.contributor.authorCengiz M.
dc.contributor.authorYildiz F.
dc.contributor.authorGenc M.
dc.date.accessioned2020-03-26T17:04:50Z
dc.date.available2020-03-26T17:04:50Z
dc.date.issued2006
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.doi10.1056/NEJMc060694en_US
dc.identifier.issn0028-4793en_US
dc.identifier.issue20en_US
dc.identifier.pmid16710908en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage2187en_US
dc.identifier.urihttps://dx.doi.org/10.1056/NEJMc060694
dc.identifier.urihttps://hdl.handle.net/20.500.12395/20781
dc.identifier.volume354en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofNew England Journal of Medicineen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleCetuximab plus radiotherapy for head and neck cancer [10]en_US
dc.typeLetteren_US

Dosyalar